Trials / Completed
CompletedNCT01193569
A Study of Survival and Outcome After Stroke
The SOS Study: A Study of Survival and Outcome After Stroke
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 142 (actual)
- Sponsor
- Penumbra Inc. · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to determine the natural history of acute ischemic stroke from large vessel thromboembolism in the brain. The target population is a stroke cohort with a known infarct volume who presents within 8 hours from symptom onset with a NIH Stroke Scale (NIHSS) score \>10 who are eligible for mechanical thrombectomy but without receiving the treatment. Functional outcome as defined by the modified Rankin Scale (mRS) of all enrolled patients will be followed for 90 days after the index event.
Detailed description
The objective of this observational study is to determine the natural history of acute ischemic stroke from large vessel thromboembolism in the brain. The target population is a stroke cohort with a known infarct volume who presents within 8 hours from symptom onset with a NIH Stroke Scale (NIHSS) score \>10. Functional outcome as defined by the modified Rankin Scale (mRS) of all enrolled patients will be followed for 90 days after the index event. This is a prospective, single arm, multi-center trial. Up to 200 patients at up to 30 centers will be enrolled in the study. It is anticipated that up to 150 evaluable patients will be needed for analysis. The sample size estimate is based on the primary study functional outcome at 90 days as defined by a mRS of 0-2. Assuming that this observational study will have as outcome of 25% (37/150) mRS 0-2 at day 90, the expected two-sided exact binomial confidence interval is (18%, 32%). This sample size is adequate to estimate the mRS outcome of 0-2 at day 90 for the natural history of acute ischemic stroke.
Conditions
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2016-12-22
- Completion
- 2016-12-22
- First posted
- 2010-09-02
- Last updated
- 2018-04-12
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01193569. Inclusion in this directory is not an endorsement.